BLACKROCK SMALLER COMPANIES TRUST PLC
All information is at 30 SEPTEMBER 2012 and unaudited.
Performance at month end is calculated on a capital only basis
One Three One Three Five
Month Months Year Years Years
Net asset value 3.7% 7.2% 18.1% 70.1% 35.8%
Share price* 3.2% 7.5% 16.7% 81.0% 36.0%
Numis ex Inv Companies + AIM* 3.4% 7.4% 14.4% 25.7% -6.6%
Sources: BlackRock and Datastream
At month end
Net asset value Capital only (debt at par value): 608.06p
Net asset value Capital only (debt at fair value): 603.87p
Net asset value incl. Income (debt at par value)**: 615.37p
Net asset value incl. Income (debt at fair value)**: 611.18p
Share price: 514.00p
Discount to Cum Income NAV (debt at par value): 16.5%
Discount to Cum Income NAV (debt at fair value): 15.9%
Net yield: 1.6%
Total assets^: £322.0m
Net gearing incl. Income (debt at fair value): 10.0%
2012 Total Expense Ratio ("TER")^^: 0.7%
Ordinary shares in issue#: 47,879,792
*without income reinvested
**includes net revenue of 7.31p
^includes current year revenue
^^As reported in the Annual Financial Statements for the year ended
29 February 2012, the TER is calculated as a percentage of net assets
and using operating expenses, excluding performance fees, finance costs
and taxation.
#excludes 2,113,731 shares held in treasury
Ten Largest Sector
Weightings % of total assets
Support Services 9.4
Software & Computer Services 9.4
Oil & Gas Producers 7.4
Electronic & Electrical Equipment 7.3
Financial Services 6.1
Industrial Metals & Mining 5.8
Chemicals 5.7
General Retailers 5.4
Media 5.4
Pharmaceuticals & Biotechnology 5.2
----
Total 67.1
====
Ten Largest Equity Investments (in alphabetical order)
Company
Ashtead
Aveva Group
Bellway
Booker Group
Galliford Try
Howden Joinery
ITE Group
Oxford Instruments
Senior
Victrex
Commenting on the markets, Mike Prentis, representing the Investment Manager
noted:
During September, the NAV on a capital only basis rose by 3.7%; the benchmark
rose by 3.4%. The FTSE 100 Index increased by 0.5% during the month.
Gearing had a slightly positive impact on relative performance; neither stock
selection nor sector allocation had much impact on relative performance during
the month.
There were no individually significant contributors to stock selection. We did
however have strong results and trading updates from a number of larger
holdings including Ashtead, Galliford Try and Hyder Consulting, and good
meetings with many other holdings including Restaurant Group, Abcam, AZ
Electronic Materials, Dunelm, Dechra Pharmaceuticals and Coastal Energy.
We added small holdings in Entertainment One and Sinclair IS Pharma.
Entertainment One is a leading international entertainment company specializing
in the acquisition, production and distribution of film and television content
across all media. It acquired Alliance Films, a similar but complementary
business making the combined entity the largest independent film distributor in
the UK and Canada, with considerable strength in many other key markets. We
took part in an equity placing to part fund the purchase. Sinclair IS Pharma
is an international specialty pharmaceutical company providing solutions to
treat wounds, dermatological & oral diseases through advanced surface technology
& innovative delivery systems. It has a growing sales and marketing operation
in the UK and Continental Europe, and an extensive marketing partner network
across selected developed & emerging markets which is generating strong sales
growth. Management has impressed us and is beginning to achieve much better
financial performance.
11 October 2012
ENDS
Latest information is available by typing www.blackrock.co.uk/brsc on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.